The Native Antigen Company Ltd

Activities: Ingredients

Trending Articles

  1. AstraZeneca invests $3.5bn into its US pharmaceutical research and manufacturing capabilities The company will expand its biologics manufacturing, as well as its speciality manufacturing and cell therapy production capacity, while also extending its pharmaceutical...
  2. The importance of accurate tare/gross weighing systems in the pharmaceutical industry Why accurate tare/gross weighing is critical in pharmaceutical settings
  3. IMed Consultancy enabling innovation in the mental healthcare sector with Limbic Limbic is a London-based start-up that is using world-leading, clinically validated Artificial Intelligence and beautiful product design to make psychological therapy...
  4. Romaco showcases its solid dosage processing portfolio at CPHI & PMEC India The company will display its portfolio suitable for the granulation, tableting, and coating of pharmaceutical solids
  5. Lonza expands bioconjugation capabilities for ADC manufacturing at Visp site The CDMO's facility will double its bioconjugate manufacturing capacity with two 1,200 L manufacturing suites

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Drug Delivery

The Native Antigen Company strengthens senior team to support growing product portfolio

Appointments of Business Development Manager and Senior Product Manager follow move to state-of-the-art new facilities at Oxford Technology Park
Research & Development

Native Antigen Company expands range of norovirus-like particles

Norovirus is a small non-enveloped, positive-sense RNA virus belonging to the Caliciviridae family. It is a major cause of non-bacterial acute gastroenteritis outbreaks
Ingredients

The Native Antigen Company introduces veterinary reagents

The range includes pathogens such as coronaviruses, Borrelia, Rift Valley fever virus, African swine fever virus, Toxocara and heartworm
Manufacturing

The Native Antigen Company launches SARS-CoV-2 antibodies

The introduction of these antibodies extends The Native Antigen Company’s existing range and offers researchers a source of reagents for research
Ingredients

The Native Antigen Company introduces custom service for influenza antigens

The reagent supplier has announced the introduction of its custom contract service to rapidly develop antigen panels for influenza A and B viruses
Research & Development

BBI Solutions partners to distribute COVID-19 antigens in China

The Native Antigen Company has agreed distribution rights with BBI to provide coronavirus reagents in China
Ingredients

The Native Antigen Company introduces novel coronavirus antigen

UK company has developed rapid response manufacturing capabilities to produce reagents for emerging epidemic diseases
Subscribe now